(Date:11/24/2009)...ire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )t...veChairman,willpresentatthe21stAnnualPiperJaffrayH...1,2009at10:00a.m.ET. ,, Toaccesstheliveandsubse...vestorRelationssectionofGenomicHealth,swebsiteat h...hewebsiteatleast15minutespriortothebeginningofthep...
(Date:11/24/2009)...cts Service (CAS), the global expert on chemical i...now the world,s leading producer of patent inventi...s patent office, the World Intellectual Property O...nd Trademark Office (USPTO) for more than a decade...exceeded Japan for the first time on a monthly bas...
(Date:11/23/2009)... origami very high-tech origami. , Researchers a...nique for fabricating three-dimensional, single-cr...upling photolithography and a self-folding process...nly a few microns thick, offer mechanical bendabil...e same material. , "This is a completely differen...
(Date:11/23/2009)...wire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PD...27,2009astheex-dividenddateforits$200millionspecia...iontransactioncompletedonNovember2,2009.Thedividen...ordontherecorddate,December1,2009.NASDAQhassetthea...reofcommonstockforpurposesoftheex-dividenddateonNo...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2...e Market Share Away from Lucentis from 2012 to 201...es , , WALTHAM, Mass., March 10 Decision Resourc...ry firms for pharmaceutical and healthcare issues,... age-related macular degeneration (AMD) market thr...e of Genentech/Novartis Ophthalmics, Lucentis in E...
..., Inc. (Nasdaq: NXTM ), a leading manufacturer o...at Jeffrey H. Burbank, Chief Executive Officer, wi...ual Healthcare Conference on Monday, March 16, 200... NxStage,s investor presentation is scheduled for ...the audio webcast of the presentation, please visi...
...er Key Regulatory Milestone , , LONDON, March 10 ...development in breeding and biotechnology has cont...e for the company,s Seeds and Genomics segment sin...eete, Monsanto,s Vice President of International C...presentation at the Credit Suisse 14th Annual Glob...
Other Biology Technology:Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 3NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference 2Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment 2Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment 3...it I provides reagents and a protein standard for ...of reducing agents and detergents. The RC DC prote... reagents and standards sufficient for 500 standar...I, 250 ml alkaline copper tartrate solution, 2 L d...
Gelatin from bovine skin from Sigma-Aldrich
...-the-art separation system using the asymmetric fl...Eclipse integrates easily with Wyatts multi-angle ...N Tristar, as well as the Optilab DSP. The combine...tributions of the particles/molecules separated by...
... for determining the absolute count of CD34+ cells...pheral blood samples, and leukapheresis samples. T...leated cell count and a total CD45 (leucocyte) cel...ocount progenitor cell enumeration system. Specie...
Biology Products: